EUROAPI

Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.

OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.

EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?

PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.

The Group actively seeks opportunities to purchase renewable electricity through long-term contracts such as Power Purchase Agreements (PPAs) and certificates such as Guarantee of Origin (GO) and Renewable Energy Certificates (RECs). In 2022, 87% of electricity purchased was derived from renewable sources, with five out of six sites using 100% renewable electricity. A 17 MW biomass boiler is being installed at Saint-Aubin-lès-Elbeuf (operational 2026, ~76% CO2e reduction vs existing gas boiler), and solar PV panels are scheduled for Haverhill in 2023. Target: 100% renewable electricity at all industrial sites by 2025.

No narrative on durable removals approach in the firm's most recent reports.

• Waste reduction and zero-waste-to-landfill

  Waste represents approximately 20% of Scope 3 emissions. The Group rolled out programs focused on waste reduction; as of 2022 two of six industrial sites achieved zero waste to landfill. Total waste sent to landfill cut nearly 30% versus 2020.

• Fleet electrification

  Group objective to have only electric and hybrid vehicles in its vehicle fleet by 2025, and electric vehicles only by 2035, addressing Scope 1 mobile combustion emissions.

• Green chemistry and process intensification (continuous flow, biocatalysis, biotech)

  Responsible Innovation program based on the 12 Principles of Green Chemistry. Examples: flow chemistry at Haverhill (largest marketed API produced via continuous chemistry); biochemistry intensification at Brindisi and Saint-Aubin-lès-Elbeuf (Project ELLA: vitamin B12 process targeting halved water consumption with €40 million investment); biocatalysis at Budapest; solid-phase peptide synthesis intensification. PMI (Process Mass Intensity) will be tracked for new projects.

• Biomass boiler and energy efficiency at manufacturing sites

  Scope 1 reductions are pursued through a 17 MW wood-waste biomass boiler at Saint-Aubin-lès-Elbeuf replacing an existing gas boiler (estimated 76% CO2e reduction, operational 2026), and a potential biomass boiler at Vertolaye. Carbon-neutral design is now mandatory for all new buildings, prohibiting fossil fuels for heating and requiring heat pumps and renewable electricity. All sites pursuing ISO 50001 energy management certification by end 2023.

• Purchased goods decarbonisation (solvents, acids/bases, biotech yield)

  Purchased goods represent almost 50% of Scope 3 emissions. The Group is implementing programs focused on solvents, acids, bases and biotechnology yield. Solvent recycling rate was 68% in 2022 with new distillation capacity being added at Frankfurt (800 t toluene/yr), Vertolaye (3,000 t study + 400 t recycling project) and Budapest (240 t acetone/yr).

• Supplier ESG due diligence and PSCI membership

  Responsible procurement program structured around supplier risk mapping, mandatory Supplier Code of Conduct signature, ESG questionnaires for higher-risk suppliers (35.5% of raw material suppliers), and remediation plans. In January 2023 the Group launched the process for joining the Pharmaceutical Supply Chain Initiative (PSCI) to share supplier audits. In 2022, three Group sites were audited according to PSCI principles. Over 71% of raw material expenditure is in Europe.